Samsung Biologics says its product carbon footprint (PCF) system has been validated by Det Norske Veritas (DNV).

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced that its product carbon footprint (PCF) system has been validated by Det Norske ...

Global mRNA Synthesis and Manufacturing Market OverviewThe global mRNA synthesis and manufacturing market is projected to grow at a compound annual growth rate of approximately 6% during the forecast ...

Puerto Rico selected as one of six U.S. sites for biopharma training. #NewsismyBusiness - Stay updated with the latest Puerto ...

Merck & Company Inc. (NYSE:MRK) operates as a diversified biopharmaceutical organisation with activities spanning medicines, ...

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best stocks under $3 to invest in. On January 9, Iovance ...

Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) ("Coeptis" or the "Company"), a next-gen technology and biopharmaceutical company, today announced that ...

VOWST sale boosts runway to Q2 2026; SER-155 Phase 2 is key after strong Phase 1b. Click here to read my most recent analysis of MCRB stock.

Akeso, Inc. (9926.HK) is pleased to announce that ivonescimab, its global first-in-class bispecific antibody targeting PD-1 and VEGF, has been granted its fifth Breakthrough Therapy ...

The inducement grants were approved by ORIC’s Compensation Committee of the Board of Directors, as required by Nasdaq Rule 5635 (c) (4), and were granted as a material inducement to employment in ...

Resume.org, the leading platform for building a resume, has released new findings from a January 2026 survey of 1,146 U.S.

The large molecule drug substance CDMO market is projected to grow at a CAGR of approximately 9% over the forecast period. This growth is primarily driven by the rising demand for biologics and ...